MYCOBUTIN caps 150 mg 30 pce

7680520680109 CH-52068 J04AB04 08.02.1.
MYCOBUTIN caps 150 mg 30 pce
MYCOBUTIN caps 150 mg 30 pce
MYCOBUTIN caps 150 mg 30 pce
1 / 3
google

Details

Product number
5206801
CPT
-
Packaging group
30
Unit
Kapsel(n)
Composition
rifabutinum 150 mg, excipiens pro capsula.

Articles (1)

Mycobutin, Kapseln
Kapseln
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
23/08/2024
Patient information leaflet
Français
23/08/2024
Patient information leaflet
Italien
23/08/2024
Professional SmPC
Allemand
23/08/2024
Professional SmPC
Français
23/08/2024
Professional SmPC
Italien
23/08/2024

Detailed composition

Substance Quantity Type Category
(N/A)
150.0 MG Substance Wirkstoff (Principe actif)
cellulosum microcristallinum
- Substance HNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
natrium
0.96 MG Substance HBESI
magnesii stearas
- Substance HNIDK
silica colloidalis hydrica
- Substance HNIDK
gelatina
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (rubrum)
- Substance FTODK

Reimbursement information

Public price
CHF 137.00
Specialties list
Yes
Generic
No
SL addition date: 15/03/1994

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
52068
Drug name
Mycobutin, Kapseln
Galenic form
KAHA
ATC Code
J04AB04
Authorization status
Z
Dispensation category
A
First authorization
25/02/1994
Authorization expiration date
31/12/9999
IT number
08.02.1.
Domain
Human medicine
Field of application
Mycobakterieninfektionen

Packaging details

Description (FR)
MYCOBUTIN caps 150 mg 30 pce
Description (DE)
MYCOBUTIN Kaps 150 mg 30 Stk
Market launch
25/02/1994
Narcotic (BTM)
No